XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information
6 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information

27. SEGMENT INFORMATION

Reportable segments

 

Prior to the three months ended September 30, 2022, the Company had the following two reportable segments: (i) global cannabis; and (ii) other consumer products. Following the completion of certain restructuring actions which were initiated in the three months ended March 31, 2022, and which were aligned with the Company's strategic review of its business, the Company has changed the structure of its internal management financial reporting. Accordingly, in the three months ended September 30, 2022, the Company is reporting its financial results for the following five reportable segments:

 

Canada cannabis - includes the production, distribution and sale of a diverse range of cannabis, hemp and cannabis products in Canada pursuant to the Cannabis Act;
Rest-of-world cannabis - includes the production, distribution and sale of a diverse range of cannabis, hemp and cannabis products internationally pursuant to applicable international legislation, regulations and permits;
Storz & Bickel - includes the production, distribution and sale of vaporizers;
BioSteel - includes the production, distribution and sale of consumer packaged goods ("CPG") including sports nutrition beverages, mixes, protein, gum and mints, some of which have been blended with hemp-derived CBD isolate; and
This Works - includes the production, distribution and sale of beauty, skincare, wellness and sleep products, some of which have been blended with hemp-derived CBD isolate.

 

These segments reflect how the Company's operations are managed, how the Company's Chief Executive Officer, who is the Chief Operating Decision Maker (“CODM”), allocates resources and evaluates performance, and how the Company's internal management financial reporting is structured. The Company's CODM evaluates the performance of these segments, with a focus on (i) segment net revenue, and (ii) segment gross margin as the measure of segment profit or loss. Accordingly, information regarding segment net revenue and segment gross margin for the comparative periods has been restated to reflect the aforementioned change in reportable segments. The remainder of the Company's operations include revenue derived from, and cost of sales associated with, the Company's non-cannabis extraction activities and other ancillary activities; these are included within "other".

 

 

 

Three months ended

 

 

Six months ended

 

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Segmented net revenue

 

 

 

 

 

 

 

 

 

 

 

 

Canada cannabis

 

$

52,304

 

 

$

71,672

 

 

$

104,719

 

 

$

145,201

 

Rest-of-world cannabis

 

 

10,552

 

 

 

23,653

 

 

 

24,333

 

 

 

43,063

 

Storz & Bickel

 

 

13,494

 

 

 

14,511

 

 

 

29,137

 

 

 

38,581

 

BioSteel

 

 

29,922

 

 

 

7,512

 

 

 

47,810

 

 

 

14,173

 

This Works

 

 

6,868

 

 

 

9,027

 

 

 

12,388

 

 

 

15,578

 

Other

 

 

4,723

 

 

 

4,999

 

 

 

9,591

 

 

 

10,987

 

 

 

$

117,863

 

 

$

131,374

 

 

$

227,978

 

 

$

267,583

 

Segmented gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

Canada cannabis

 

$

(7,652

)

 

$

(91,980

)

 

$

(20,185

)

 

$

(84,804

)

Rest-of-world cannabis

 

 

(1,332

)

 

 

10,978

 

 

 

(1,492

)

 

 

19,585

 

Storz & Bickel

 

 

6,002

 

 

 

5,351

 

 

 

11,623

 

 

 

16,451

 

BioSteel

 

 

4,432

 

 

 

(404

)

 

 

6,865

 

 

 

(3,713

)

This Works

 

 

2,303

 

 

 

3,558

 

 

 

4,950

 

 

 

6,954

 

Other

 

 

68

 

 

 

1,357

 

 

 

668

 

 

 

1,625

 

 

 

 

3,821

 

 

 

(71,140

)

 

 

2,429

 

 

 

(43,902

)

Selling, general and administrative expenses

 

 

125,842

 

 

 

125,756

 

 

 

229,255

 

 

 

238,330

 

Share-based compensation

 

 

9,858

 

 

 

15,953

 

 

 

15,297

 

 

 

29,079

 

Asset impairment and restructuring costs

 

 

43,968

 

 

 

2,510

 

 

 

1,771,953

 

 

 

91,759

 

Operating loss

 

 

(175,847

)

 

 

(215,359

)

 

 

(2,014,076

)

 

 

(403,070

)

Loss from equity method investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(100

)

Other income (expense), net

 

 

(47,844

)

 

 

195,821

 

 

 

(293,422

)

 

 

776,487

 

(Loss) income before incomes taxes

 

$

(223,691

)

 

$

(19,538

)

 

$

(2,307,498

)

 

$

373,317

 

 

Asset information by segment is not provided to, or reviewed by, the Company’s CODM as it is not used to make strategic decisions, allocate resources, or assess performance.

 

Entity-wide disclosures

Disaggregation of net revenue by geographic area:

 

 

 

Three months ended

 

 

Six months ended

 

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Canada

 

$

86,012

 

 

$

80,184

 

 

$

160,461

 

 

$

162,796

 

Germany

 

 

11,247

 

 

 

22,370

 

 

 

23,611

 

 

 

48,476

 

United States

 

 

8,783

 

 

 

18,225

 

 

 

20,396

 

 

 

38,092

 

Other

 

 

11,821

 

 

 

10,595

 

 

 

23,510

 

 

 

18,219

 

 

 

$

117,863

 

 

$

131,374

 

 

$

227,978

 

 

$

267,583

 

 

Disaggregation of property, plant and equipment by geographic area:

 

 

 

September 30,

 

 

March 31,

 

 

 

2022

 

 

2022

 

Canada

 

$

747,355

 

 

$

827,591

 

Other

 

 

117,168

 

 

 

115,189

 

 

 

$

864,523

 

 

$

942,780

 

 

For the three months ended September 30, 2022, no customer represented more than 10% of the Company’s net revenue (three months ended September 30, 2021 – none).

 

For the six months ended September 30, 2022, no customer represented more than 10% of the Company's net revenue (six months ended September 30, 2021 – one)